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ABSTRACT 
 
Cleistanthus collinus poisoning is common in rural south India. Water extract of 
Cleistanthus collinus leaves is a common suicidal poison. Victims consume either 
a boiled decoction (FLB, fresh leaves boiled) or fresh leaves blended and filtered. 
Mortality is about 28% and is stated to be higher with boiled decoction. 
Aim 
The aim of the present study was to develop an antidote for Cleistanthus collinus 
poisoning 
Objectives 
(1)To get the minimum lethal dose (MLD100) of FLB, FLG, purified Cleistanthin 
A and C .  
(2) To see if a particular fraction of Cleistanthus collinus extract (non fluorescent 
fraction of cold water extract, NFF) can prevent death in rats when administered 
after administering the lethal dose of boiled water extract / cleistanthin C.  
Methods 
Boiled decoction and fresh leaf ground extract was prepared and minimal lethal 
dose for the same was estimated. Toxic principles, Cleistanthin A and C was 
isolated to its single peak purity for experiments. Non fluorescent fraction (NFF) 
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to try as an antidote was prepared from fresh leaf ice cold extract of C.collinus 
leaves. NFF was administered to the rats poisoned with boiled extract or 
cleistanthin C. Toxins were administered via oral  gavage. 
Results 
Minimum lethal dose (MLD100) of FLB, FLG, purified Cleistanthin A and C in 
rats was determined. There is not much difference in MLD100 for FLB 
(75mg/100gm) and FLG (50mg/100gm) in rats. The concentration of Cleistanthin 
C in the MLD100 of FLB is sufficient to account for lethality of FLB. However, 
the concentrations of both Cleistanthin C and Cleistanthin A are insufficient to 
account for lethality in the case of FLG. Therefore we conclude that, the toxicity 
of fresh leaf ground is neither due to cleistanthin A or C , but due to a yet 
unidentified compound. Experiments with NFF as an antidote in C.collinus 
poisoning are yet to be standardized. 
 
Keywords: 
Cleistanthus collinus , Cleistanthin A, Cleistanthin C, Plant poisoning, TLC, 
HPLC 
 
 
 7 
 
 
 
 
  INTRODUCTION 
 
  
 8 
 
Paracelsus (1493-1541) said in the sixteenth century, "the dose makes the 
poison." Poisons include both naturally produced compounds and chemicals 
manufactured by humans. Natural poisons are produced by species of 
bacteria, fungi, protists, plants, and animals. 
 Plant poisoning is a major clinical problem in the developing countries(Eddleston 
and Persson, 2003). Almost all deaths result from suicide or homicide. Treatment 
for most plant poisonings is symptomatic and specific antidotes are available only 
for a few. Unfortunately, their great cost limits their use in the developing world 
where they would make a major difference in patient management. 
Cleistanthus collinus (commonly known as Oduvanthalai in Tamil) is a highly poisonous 
shrub of the Euphorbiaceae family(Govindachari et al., 1969) found in southern India. 
Along the eastern coast of the peninsula and in some pockets of interior Tamil Nadu, the 
Oduvan leaves are crushed and consumed as a boiled decoction for suicides. The suicide 
victim is usually of low socio economic status .Typically a handful of leaves is boiled  
and consumed. The dangerous period during which death is likely to occur is third or 
fourth day after consumption of the toxic extract. The boiled extract of leaves is more 
poisonous than the fresh or ground leaves
   
(Shankar et al., 2009)
 
.  
          Pioneering work towards isolation of active principles from C.collinus was done by 
Govindachari et al who had isolated a large number  of known and unknown fractions 
from C.collinus (Govindachari et al., 1969). Among the compounds that were identified, 
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the important ones were Diphyllin, collinusin and cleistanthin A which are lignan 
lactones. Cleistanthin B was identified by Subba Rao in 1960 (N.V.Subba rao, 1960). 
Thin layer chromatograms reveal that all the above four compounds are intensely 
fluorescent under UV light, each fluorescing with a characteristic colour. In  fact, almost 
21 different compounds have been identified (Pinho and Kijjoa, 2007). K.S.Annapoorani 
has shown that of the four tested fluorescent compounds, Diphyllin and Collinusin were 
nontoxic while Cleistanthin A and B were toxic in rats (K.S.Annapoorani,Ph.D Thesis.).  
           Mortality rate in patients is as high as 28% and death usually occurs 3-7 days after 
ingestion of the poison
 
(Thomas et al., 1991). Molecular mechanism of oduvan poisoning 
is still an unsolved problem. The patients develop life threatening complications such as 
hypokalemia(56.5%),hypotension(17.5%), cardiac arrhythmias, neuromuscular weakness, 
reapiratory distress(15.8%) and renal failure(25.3%) following a transient quiescent 
period of upto four days (Eswarappa et al., 2003).  
Retrospective chart review of 97 patients admitted with C.collinus poisoning to Medicine 
department at Christian Medical College, Vellore during the period of 1997-2004 reveals 
that mortality was 26% even with treatment(Zachariah A et al.)  At admission, laboratory 
abnormalities were leucocytosis (64%), hypokalemia (56%), acidosis(86%) and renal 
failure (25%). Complications occurring during hospitalization were hypotension (17%), 
bradycardia (11%), ARDS (4%) and new onset acute renal failure (10%). Patients were 
treated with gastric lavage (68%), potassium supplementation (87%), temporary pacing 
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(93%), continous cardiac monitoring (83%), mechanical ventilation (24%) and dialysis 
(2%). Factors associated with mortality were hypokalemia, renal failure, shock, metabolic 
acidosis and ARDS. None of the above interventions were found to improve survival. 
Case reports are there to show patients developed  features of distal ranal tubular 
acidosis.(Benjamin et al., 2006; Eswarappa et al., 2003)  
Animal studies have been done to identify the mechanism of toxicity of C.collinus from 
various angles: Proposed mechanisms of actions are, distal renal tubular acidosis, 
electrolyte imbalance, neuromuscular blockade resulting in respiratory paralysis 
(Nandakumar et al., 1989), inhibition of LDH isoenzymes (Kanthasamy A et al,1986.), 
glutathione and ATP depletion (Sarathchandra G et al,1997), K
+ 
channel blocker (Jose et 
al., 2004). Cytotoxic nature of Cleistanthin A and B was demonstrated against several cell 
lines. Irrespective of all these extensive work, the exact cause of death is still a mystery. 
 No specific antidote discovered till date. A study on the use of multiple doses of charcoal 
on patients within 24 hrs of presentation demonstrated a mortality benefit, but further 
studies are required
 
(Raja G et al,2007.)
 
. N-acetylcysteine, L-cysteine, melatonin and 
thiol compounds have all been suggested as possible antidotes in C.collinus  poisoning 
(Jayanthi et al., 2009,Benjamin et al., 2006)
 
. In one case, use of N-acetylcysteine as 
treatment has been reported, but beneficial effect is still not clear. Neostigmine was also 
tried in a patient who presented with a myasthenic crisis-like syndrome (Damodaran et 
al., 2008).  
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Research in our department is focused on the mechanism of action of oduvanthalai 
poisoning and to find a specific antidote for the same. In our lab, animal 
experiments with whole aqueous extract of oduvanthalai leaf showed type I DRTA 
(hypokalemia, alkaline urine and metabolic acidosis)
   
(Maneksh et al., 2010) as in 
human cases, but type II respiratory failure too, which is not seen in humans. The 
molecular mechanism of DRTA was determined to be inhibition of the proton 
pumps in the brush border membrane of distal renal tubule. However, this may not 
be the cause of death in oduvan poisoning, because Cleistanthin A and 
Cleistanthin C, when administered in pure form, resulted in death, without 
evidences of DRTA or type 2 respiratory failure. Experiments with Diphyllin 
showed that it is non-toxic and neither did it produce DRTA . Patch clamp studies 
showed that the aqueous extracts blocked the voltage gated channels, but not seen 
with the individual compounds. 
Till date, our lab has performed whole animal experiments with intraperitoneal 
administration of the toxins. That may be the reason why the clinical picture does 
not match the human condition exactly. However, the experiments have helped us 
determine the electrolyte and ABG profiles during the course of the toxicity.  
Some studies have reported that Cleistanthin A is safe upto 800mg/kg 
orally,(Parasuraman and Raveendran, 2012) but, even 20mg/kg intraperitoneally 
resulted in 100% mortality in the studies done in our lab. However, it is also 
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reported that Cleistanthin A and B are not present in the aqueous extracts of 
C.collinus leaves (Subramani, 2014.) Discrepancies spurred  us on  to design and 
carry out experiments to determine oral toxic dose of clinically relevant extract  
and toxic constituent of C.collinus .  
Therefore, experiments were designed to answer these questions to our best 
abilities.  
Minimal lethal dose which cause 100 % mortality has been estimated for  fresh 
leaf boiled extract , fresh leaf ground extract, Cleistanthin A and Cleistanthin C of 
Cleistanthus collinus . 
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 REVIEW OF LITERATURE 
The World Health Organization (WHO) estimated that 80% of the population of 
developing countries relies on traditional medicines, mostly plant drugs, for their 
primary health care needs.Also, modern pharmacopoeia still contains at least 25% 
drugs derived from plants and many others which are synthetic analogues built on 
prototype compounds isolated from plants. 
There are many plants containing poisonous parts that pose a serious risk 
of illness, injury, or death to humans or animals. Many of these poisonous 
compounds also have important medicinal benefits. 
What is a poison? 
To be precise, a poison is a foreign chemical (xenobiotic) that is capable of 
producing a harmful effect on a biologic system. 
What is a toxin? 
It originally referred to a poison of animal or plant origin 
Toxicant is the currently preferred scientific term for all poisons.  
 
What is a toxidrome? 
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It is the association of several clinically recognizable features, signs, 
symptoms, phenomena or characteristics which often occur together, so that 
the presence of one feature alerts the physician to the presence of the 
others.   
Recognition of poisoning 
May be difficult because of non-specific symptoms. 
High index of suspicion  is required, especially in acute poisoning. 
 History may be unreliable 
 Look for corroborative history  
 Course that a poison runs (toxidromes)  
Toxicology screening - helpful only in a few cases because of very diverse 
and varied presentation.  
Goals of treatment 
 Reduce absorption of the toxin (xenobiotic) 
 Enhance elimination 
 Neutralize toxin 
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Virtually all plants contain poisons as a defense mechanism.In most cases, their 
toxins are removed through cooking or digestion.Many of these natural toxins, 
acts to disrupt the biological machinery at the level of signal transduction 
mechanisms or the essential metabolic pathway. Some poisons are powerful 
enough to a grinding halt with just a trifling amount, while others are slower in 
their effect. 
Poisons found in plants are of four primary kinds, namely, alkaloids, glycosides, 
resins and essential oils. It is a major clinical dilemma as antidotes are not 
available for most of the plant poisons. Therapy for some other plant poisonings 
might also benefit from the development of antitoxins. Antitoxin antibodies are 
available for only two plant families and for just one of these are antitoxin 
antibodies in current clinical practice. However, until issues of cost and supply are 
worked out, plant anti-toxins are going to remain a dream in many of the areas 
where they are now urgently required.  
This study is concerned with a poisonous plant called Cleistanthus collinus which 
is native to southern India.It is commonly used as a suicidal poison in this part of 
world(Chopra, 1965). Availability and easy accessibility are probably the reason 
for the consumption of this poison (Chrispal, 2012a). Even though the toxic 
constituents of the plant are capable of causing 28% mortality, their exact 
mechanism of action still evades science. Treatment is only symptomatic. No 
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specific antidote is available against this toxin(Subrahmanyam et al., 2003). Let 
alone the quest of designing an antidote.  
Oduvanthazhai is a highly poisonous shrub of the Euphorbiaceae family 
(Govindachari et al., 1969). Euphorbiaceae is a highly diversified family with 
substantial difference in morphology, chemical and ecological characteristics. This 
family is widely distributed throughout with approximately 8000 species of plants. 
The genus cleistanthus comprises about more than hundred species ranging from 
shrubs to trees. Cleistanthus collinus is a plant poison also called "Oduvan" in 
Tamil, "Vadise" in Telugu, Nilappala or Oduku  in Malayalam, Garari in Hindi. 
The name derives from Euphorbus, the physician to King Juba of Mauritania ( 50 
BC-23 AD) who discovered the therapeutic properties of Euphorbiaceae plants. 
Euphorbiaceae family includes  large desert succulent to small herbaceous plants 
and trees in forest. The presence of latex ( milky sap ) is characteristic of plants 
from spurge family. Some species of the spurge family contain potent systemic 
toxins, including Ricinus communis L. ( ricin ),Cleistanthus collinus (Roxb) Hook. 
F.  The extracts of these two species are  ancient homicidal agents in India. 
Common Name : Oduvan, Garari, Karrada, Pasu, Karlajuri 
Scientific Name : Cleistanthus collinus (Roxb.) Hook .f. 
Botanical Family : Euphorbiaceae ( spurge ) 
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Distribution and Ecology : Cleistanthus collinus is a native plant of India, 
Malyasia, Africa. 
Physical description : Cleistanthus collinus is a small deciduous tree or shrub with 
spreading rigid twiggy branches. Leathery and glaborous leaves about 3.5 to 10 
cm long and arranged alternately. They are orbicular, obovate or elliptic. Five to 
six pairs of main lateral leaves are present. Fruits are generally dark brown and 
woody. Seeds are globose. Almost all parts of the plant contain toxic compounds. 
 
Figure 1 : Cleistanthus collinus plant 
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The hard wood of the plant is durable and used in making agricultural implements. 
Posts, poles, fence, etc. are made from this wood as it is not attacked by white 
ants. Leaves are used as manure.Tannins isolated from the bark of the plant are 
used in leather industry. 
The bark of the plant is considered to have useful application in cutaneous 
disease.Water in which leaves are steeped are used as a treatment option for 
headache . Cleistanthus collinus has been investigated for its antibacterial, 
antifungal, antiprotozoal, antiviral, anticancer, diuretic and hypoglycemic 
effects(Suman.T, 2013),  (Pradheepkumar and Shanmugam, 1999),  (Vishal L. 
Bagde, 2013).  
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The leaves of this plant have been known to be used for suicidal and homicidal 
purposes . Almost all parts of the plant are reported to be highly toxic. FRoots and 
leaves are used as cattle poison, bark and seeds of the plant are used as fish poison. 
The leaves are mainly exploited for suicidal, homicidal, cattle poisoning and for 
doing criminal abortion (Devaprabhu S, 2007). 
This poison is consumed in two ways. Either the fresh leaves are crushed and the 
filtered juice is consumed or a boiled decoction ( aqueous extract ) or consumes as 
a paste made with these leaves or swallows the crushed leaves  (Thomas et al., 
1987).  The boiled extract of the leaves is more poisonous than the fresh or ground 
leaves (Thomas et al., 1987). This might be due to release of toxic components 
from leaves after boiling. 
Clinical presentation of cleistanthus collinus poisoning varies from nausea to 
death.Patients may be asymptomatic too. 
The usual presenting symptoms are gastrointestinal symptoms of nausea, 
vomiting, diarrhea, abdominal pain, dysphagia and decreased bowel 
movements.(Chrispal, 2012).  
Some patients complains of chest pain, breathlessness, dizziness (Nagaraj S, 
1987).   
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Documented clinical neurological abnormalities are visual disturbances, muscle 
cramps and weakness, altered sensorium, giddiness, headache, altered speech, 
tremors  (Subrahmanyam et al., 2003a)(Eswarappa et al., 2003)(Benjamin et 
al.,2006). 
 Fever within the first 96 hours of admission, and dehydration have also been 
recorded (Shankar et al., 2009).  
 Clinical features reported repeatedly are  
1. Distal renal tubular acidosis which is a triad of hypokalemia, metabolic acidosis 
and alkaline urine .  
2. Intractable hypotension(5).   
Though cardiac arrhythmias were  reported earlier, current opinion says that there 
is no cardio toxicity .We have demonstrated an animal model with intraperitoneal 
injection of water decoction of C.collinus leaves(4). In this model DRTA occurred 
repeatedly similar to human cases.  However, type II respiratory failure also 
occurred which is never seen in patients.What is reported in patient is in fact a 
type I respiratory failure(6). The discrepancy in our model versus the patient 
findings could be due to differences in the route of toxin administration.  While 
patients consume the toxin orally we had resorted to intraperitoneal 
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administration, because of the ease of using the anaesthetized animal for recording 
ECG, respiration and blood pressure. 
Reported laboratory abnormalities includes 
 Hypokalemia,  
Hyperchloremic high anion gap acidosis,  
Leucocytosis,  
Coagulopathy,  
Elevated enzyme levels of alkaline phosphatase, transaminases,  
Hyponatremia,  
Hyperbilirubinemia, 
 Type 1 distal renal tubular acidosis,  
ECG changes like QTc prolongation and ST changes 
 (Subrahmanyam et al., 2003) (Eswarappa et al., 2003) (Nampoothiri et al., 2010). 
The mainstay of C. collinus poisoning management is  close monitoring and 
correction of electrolyte imbalances. 
 Aggressive  correction of potassium and, acidosis is crucial.  
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Shock management with crystalloids and inotropes (both epinephrine and 
dobutamine ) is indicated. Cardiogenic cause for shock yet to ruled out. 
 Renal function with strict intake-output monitoring, central venous access and 
serum creatinine levels (Nampoothiri et al., 2010) .  
The exact role of cardiac pacing in the setting of C. collinus poisoning is a matter 
of conjecture as the evidence for reducing mortality rate through its use is 
inadequate. Indicated in the setting of  rhythm disturbances such as bradycardia 
and QTc prolongation, and may be  placed electively in patients with severe 
poisoning. It is unlikely that elective pacemaker insertions for all patients with C. 
collinus poisoning will be of benefit, and studies on its indications and its duration 
of use are needed .(Thomas et al., 1991) . Cardiac monitoring may be required up 
to 5 days in symptomatic patients. 
 Mechanical ventilation is indicated in the setting of respiratory failure. 
N-acetylcysteine has been suggested as possible antidote for management of C. 
collinus toxicity.(Annapoorani KS et al, 2003). N-acetylcysteine has been reported 
to be used, but the benefit of this intervention is unclear (Benjamin et al., 2006). 
Neostigmine was used for a patient who presented with a myasthenic crisis–like 
syndrome (Damodaram et al., 2008).  
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Other compounds suggested as possible antidotes  for treatment of Cleistanthus 
collinus poisoning are L-cysteine, melatonin and thiol-containing compounds, but 
the benefit is unclear (Jayanthi et al., 2009) (Sarathchandra G et al, 2000) 
(Sarathchandra G et al, 1997) . 
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Figure 2 
Management  protocol based on current evidence (Chrispal, 2012) 
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PHYTOCHEMISTRY OF CLEISTANTHUS COLLINUS 
The genus cleistanthus  comprises about 140 species among which only four 
species have been investigated in detail. Study of chemical nature of cleistanthus 
collinus Roxb., demonstrates the presence of arylnaphthalide lignans and their 
glycosides as well as some furofuranoid lignans.  
The compounds so far isolated from the plants of genus cleistanthus are lignans , 
terpenoids, ellagic acid, gracicleistanthoside. Lignans include arylnaphthalide 
lignans,furofuranoid lignans and dibenzylbutanone lignans. Terpenoids comprises 
triterpenes, diterpenes. 
Cleistanthus collinus is composed of many toxic and non toxic constituents . 
Naidu et al isolated “ Oduvin ’’ from the leaves to the toxicity of C.collinus was 
attributed(Subramanyam CA RNS, 1944). Oduvin was reported to be slow poison.  
Subsequent investigation of oduvin by Irudayasamy and Natarajan showed it to 
contain Principle A and Principle B. chemical investigation of leaves of 
cleistanthus collinus led to isolation of lignin lactones like cleistanthin A, 
collinusin and diphyllin besides β sitosterol and ellagic acid. 
Arylnaphthalide lignans are the major constituents and they were isolated both as 
free  and as glycosides. Diphyllin was isolated from the leaves and the heartwood 
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of the plant cleistanthus collinus (Govindachari et al., 1967) (Anjaneyulu et al., 
1981).  
Collinusin and cleistanone were reported to be present in aerial parts of the plant 
(Govindachari et al., 1967) (Chinmai Ramesh, 2003).D iphyllin glycosides have 
the sugar moiety on C-4 of diphyllin. Govindachari et al isolated ellagic acid, 
Diphylllin and lignan lactones namely cleistanthin and collinusin from 
Cleistanthus collinus  leaves (Govindachari et al., 1967).  
Subba Rao reported the presence of another compound which had the structure 
diphyllin- O-glycoside and named it as Cleistanthin B and the earlier identified 
cleistanthin as Cleistanthin A. Cleistanthin A and Cleistanthin B have been shown 
to be glycosides of diphyllin (Annapoorani et al., 1984).   
Cleistanthin E is the only triglycoside isolated from the plant of this genus 
(Anjaneyulu et al., 1981).  
Cleistanthin C  contained 2,3-di-o-methyl-β-D –xylopyranosyl9—40-β-D-
glucopyranose,the sugar moiety of cleistanthoside A was also isolated from the 
heartwood of C.collinus(Anjaneyulu et al., 1981) (Chinmai Ramesh et al., 2003). 
Furafuranoid lignans isolated from the genus cleistanthus are sesamin, 4- 
hydroxysesamin, paulownin and wodeshio were isolated only from C.collinus 
(Anjaneyulu et al., 1981). Dibenzylbutane ligan present in C.collinus is 
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dihydrocubebin(Anjaneyulu et al., 1981). Ellagic acid was also reported to be 
present in C.collinus (Govindachari et al., 1967). Cleistanthin (C28H28O11), a grey 
crystalline compound, with a melting point of 135-136 degree, was the main 
compound. On methanolysis in the presence of acid, it gave rise to diphyllin.  
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Figure 3 : 
CLEISTANTHIN B  
 
Molecular Formula 
 C27-H26-O12 
Molecular Weight 
 542.4904 
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Figure 4: CLEISTANTHIN A CAS No: 25047-48-7 
 
Molecular Formula  C28 H28O11 
 
Molecular weight   540.52 
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Figure 5 : COLLINUSIN 
 
Molecular Formula C21 H18 O6 
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PROPOSED MECHANISM OF ACTION 
 
As the exact mechanism of action of Oduvanthazhai is still unknown, many 
possible mechanisms have been suggested by many research groups. Most of them 
could be the downstream effect of a single still undetected main action. The 
suggested actions of Oduvanthazhai are: 
Sodium Potassium Pump Inhibition 
Inhibition of LDH isoenzymes  
Depletion of Glutathione and Adenosine Tri phosphatase 
Potassium channel blocker 
Blocker of Neuromuscular Junction 
Neutrophilic granulocytosis 
Inhibition of DNA synthesis by Cleistanthin A 
Cytotoxic and genotoxic effect of Cleistanthin B 
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Sodium Potassium Pump Inhibition 
In 1997, Sarathchandra et al., showed inhibition of ATPase activity ( Sodium 
Potassium ATPase and Magnesium ATPase ) in both rats and rabbits. The clinical 
picture of patients  with oduvanthazhai poisoning showed hypokalemia, kaliuresis 
and diuresis (Kurien et al.,1991). Cardiac glycosides are known blockers of 
sodium potassium pump. Oduvanthazhai being a glycoside was also expected to 
act in a same way. 
Inhibition of LDH isoenzymes 
Aqueous leaf extract was given intravenously to the test rabbits while distilled 
water was given to control rabbits. After three days, the test rabbits were sacrificed 
along with their controls.Blood samples were collected and tissue samples  were 
taken from heart, liver, kidney. They were homogenized and used for assay.In the 
seum and tissue of test animals, the LDH activity was markedly reduced as 
compared to the controls. Among the tissues , kidney shwed the maximum 
decrease in the LDH levels (Kanthasamy et al.,1986) 
 
Inhibition of Enzymes 
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The boiled extract was given to rats and rabbits followed by which they were 
sacrificed after 2hours. Tissues like brain ,heart , liver,kidney, skeletal muscle 
were used for glutathione assay and ATPase estimation. Glutathione profile 
revealed depletion in organs of rats and in rabbits as compared to that of  controls 
in the respective species. A similar trend of inhibition of ATPase activity is 
observed in the vital organs of rats as well as in case of rabbits. Cleistanthus 
collinus  during its assault causes a definite depletion of thiol containing enzymes 
which is responsible for the manifestation of toxicity and this finding could pave 
way for the selection of thiol compounds as probable antidotes to combat 
C.collinus toxicity (Sarathchandra et al., 1997) 
Potassium channel Blocker 
Minoxidil and Glibenclamide are known potassium channel blockers. Influence of  
minoxidil and glibenclamide on cleistanthus collinus induced toxicity was studied 
ED 50 for arrhythmia, changes in contractility and heart rate were recorded . 
Cleistanthus at low doses caused a transient tachycardia and increase in 
contractility  and at a high dose caused arrhythmia and cardiac arrest (Jose et 
al.,2003) 
Neutrophilic  Granulocytosis 
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Rao et al observed neutrophilic granulocytosis in rats injected with cleistanthin. 
Hence, the toxicity of the extract was tested in different species.  
Cleistanthin was isolated from acetone extract of cleistanthus collinus 
leaves .Solution was administered viaoral and parenteral modes (IV, SC, IM) 
respectively. The study was conducted on albino rats, swiss mice, rhesus monkeys 
and mongrel cats. Post administration, leucocyte count was done with improved 
neubauer haemocytometer. Neutrophil count was done using leishman’s staining 
and haemoglobin was assessed by Sahli-Helinge method . There was a significant 
dose dependent and species dependent neutrophilic granulocytosis. It also 
depended on the route of administration. It was seen that  intravenous and  
intraperitoneal were more toxic compared to oral. The exact role of cleistanthin 
induced neutrophilic granulocytosis is yet to be investigated ( Rao et al.,1970) 
 
NEUROMUSCULAR BLOCKADE 
Toxic symptoms of cleistanthus collinus include muscle cramps and weakness, the 
effect of the leaf extract on the electrical and mechanical responses to nerve and 
muscle stimulation was studied in the isolated phrenic nerve diaphragm 
preparation of the mouse (Nandakumar et al.,1996). Following an hour’s exposure to 
0.015% extract, the response compound nerve action potential to supramaximal nerve 
stimulation was reduced by 38%. The compound muscle action potential of muscle 
reduced by 97% and isometric tension was reduced by 38%. Ther was only 11% 
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reduction in resting membrane potential.The tension and compound action potentials 
were monitored using an in vitro electromyography chamber. The intracellular recordings 
were done for resting potentials, miniature end plate potentials and end plate potentials. 
The amplitude of miniature end plate potentials reduced by 72% and shortened fall time 
by 53% indicating a post junctional inhibition similar to curare. The irreversible effects 
was attributed to the structural alterations in the neuromuscular junction which in turn 
caused symptoms such as respiratory failure, muscle weakness and cramps (48). 
Albino rat model suggests that cleistanthus collinus can result in neuromuscular 
junction blockade, particularly at the post synaptic acetylcholine receptors without 
affecting excitation contraction coupling of the muscle fibres. 
 
INHIBITION OF DNA SYNTHESIS 
Cleistanthus collinus has been screened for its  anti protozoal, anti fungal, 
anti bacterial, anti viral , anti- inflammatory, anti cancer, or any other 
pharmacological activities in Central Drug Research Institute in 1969(54).  
 Anti cancer property of Cleistanthus collinus has been observed  against 
human epidermal carcinoma of nasopharynx in tissue culture (Bhakuni et 
al.,1969), Walker carcinosarcoma 256  and L-1210 lymphoid leukemia in mice 
(Pradheepkumar et al.,2000). In  Various studies the lignans have been tested for 
its anti cancer property. Tumorigenic effects of Cleistanthin A and B on K-562 
tumour cell lines showed a reduction  of nucleotides incorporation  into the DNA 
 37 
 
and RNA. Replication and transcription steps are affected sparing the translation 
process (Rajkumar S et al., 2001). MT2 cell lines incubated with cleistanone 
,diphyllin product exhibited cytotoxicity (Ramesh et al.,2003). Cleistanthin B was 
found to be toxic against normal and tumour cel line. Cleistanthin B appears to 
have less affinity to bone marrow,fibroblasts, peripheral blood lymphocytes and 
oral fibroblasts. Human cancer cell lines showed higher sensitivity to this toxin 
than the three human normal cell types examined( Pradheepkumar et al.,1996 ) 
Detailed studies in Cleistanthin B showed that it affected the DNA synthesis by 
G1 phase arrest of mitosis and caused subsequent apoptosis ( Pradheepkumar et 
al.,1996 ). Time lapse video microscopic recordings of cleistanthin A treated cells 
showed vigorous membrane blebbing, characteristic of apoptosis. Cleistanthin A 
resulted in DNA strand breaks and cell apoptosis at higher concentrations ( 
Meenakshi et al., 2000).Matrix Metalloproteinase 9,(MMP-9) which is involved in 
extracellular matrix remodelling was inhibited by cleistanthin A , thereby viability 
of proliferating cells was reduced (Pinho et al., 2007). 
Pinho and Kijjo compared the Cleistanthin A cytotoxicity with that of 5 known 
anti cancer drugs. Cleistanthin A cytotoxicity was prominent in cancer cell lines 
and the tumor mass was reduced. But the higher concentrations of Cleistanthin B 
exhibited cytotoxicity against the normal cells along with the tumorigenic cells 
(Pinho et al., 2007)..Hence, its cytotoxicity was tested against normal and 
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tumorigenic cell lines. At higher doses, the DNA breaks and chromatid aberrations 
made by cleistanthin B in the normal cells were irreparable. Prabhakaran et al., in 
1996 found that it can break chromatids and isochromatids in Chinese hamster 
ovary(CHO)cells. It also induces micronucleus formation in cultured lymphocytes.  
 
Distal Renal Tubular Acidosis & Type II Respiratory Failure: 
Renal tubular acidosis (RTA) is applied to a group of transport defects in the 
reabsorption of bicarbonate (HCO3-), the excretion of hydrogen relatively normal 
GFR and ion (H+), or both. 
The RTA syndromes are characterized by a a metabolic acidosis accompanied by 
hyperchloremia and a normal plasma anion gap.  
Distal RTA (type 1) has been defined as a disorder of renal tubular function 
characterized by hypokalemia, hyperchloremic acidosis and the inability to lower 
urine pH  below 5.5. In the subcohort , six patients fulfilled the criteria for dRTA. 
In our lab ,a series of in vivo experiments  was performed to address this problem. 
We developed an animal model to study the molecular mechanisms of the toxin 
(Maneksh et al., 2010). The boiled aqueous and acetone extract of Cleistanthus 
collinus were used. The intraperitoneal route was chosen. The respiratory rate, 
heart rate, pressure, arterial blood gases and electrolytes were monitored over a 
period of 8 hours. The test rats showed severe respiratory acidosis with alkaline 
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urine. This indicated that the acid secreting mechanism was affected, that is, a type 
I Distal renal tubular acidosis. The renal brush border membrane  was isolated to 
measure the total ATPase activity by measuring the amount of inorganic 
phosphate formed. Venous blood samples, where the RBC have the same 
ATPases, were incubated with the acetone extract and plasma potassium levels 
were measured. In vitro experiments on the rat kidney demonstrate that there is 
ATPase inhibition in the brush border as well as the basolateral membrane of the 
distal renal tubules ,sparing of the sodium potassium ATPases. The in vivo 
experiments indicated that the respiratory failure may be of central origin which 
caused the death of the rats. In addition to the DRTA seen in rat in vivo 
experiments, the severe respiratory acidosis that was also seen must be 
contributing to the mortality due to toxic extract and has to be explored further. 
Vacuolar ATPase (proton pump) inhibition was further confirmed on rat renal 
basolateral membrane and brush border membrane by incubating them with boiled 
extract( Kettimuthu et al., 2011). 
Suggested Treatment Modalities:  
Jose et al observed the effects of potassium channel modulators such as Minoxidil, 
Glibenclamide on Cleistanthin’s boiled extract induced toxicity. The 
pharmacological modulators tried in treatment did not improve this scenario. The 
study conclusion was these drugs cannot be used in acute cardiac toxicity . 
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It is known that Oduvan poisoning causes oxidative stress in tissues, especially 
heart and  brain. Jayanthi et al proposed the use of melatonin and cysteine to 
reverse oxidative stress (53). The toxin was administered orally along with 
melatonin in wistar rats. Following their death, blood was collected for 
malondialdehyde, glutathione, catalase and glutathione peroxidase assays. Brain & 
heart tissues was processed for histopathological examination. After oduvan 
administration, the antioxidants significantly reduced the malondialdehyde levels. 
But, there was no depletion of glutathione levels contradictory to the study done 
by Sarathchandra et al. Hence, the beneficiary effects of the antioxidants on 
glutathione could not be assessed. Histopathological examination done after 
antioxidant treatment showed reversal of brain damage but not the heart damage. 
The damage control was pronounced with melatonin. However, it did not improve 
the survival. Hence, melatonin can be used to control oxidative stress in 
Cleistanthus collinus poisoning but cannot be used as an antidote . 
 
DIAGNOSTICS 
An enzyme linked immunosorbent assay (ELISA) was reported for the 
quantification of the active principlesof C,collinus (Raghupathi et al.,1992).This 
method was found to be very sensitive as it detects 2ng/ml of cleistanthin B and 
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3ng/ml of cleistanthin A.ELISA can be applied for oduvan identification in 
clinical and forensic toxicology. 
Spectrofluorometric quantitation of diphyllin and its glycosides has been 
mentioned by K.S A nnapoorani.This method is highly reproducible and sensitive 
to 0.1µg/ ml of cleistanthins in blood. 
Cleistanthin B was also estimated by a solid state fluorodensitometric 
method(Ragupathi et al.,1992). It can measure the hapten at nanogram level.  
Cleistanthin B was conjugated with bovine serum albumin followed by a TLC on 
silica gel.. The concentration of Cleistanthin B was obtained by a standard graph 
plotting the peak area against the concentration. This was chromatographed with a 
control, that is, a known amount of conjugate.  The number of molecules was also 
determined from UV spectral data of the three components  known as the UV 
method. Cleistanthin B was determined by determining the number of free amino 
groups in the protein, called the TNBS method. 
Thin layer chromatographic detection of the lignan lactones has been developed 
by Subramanian et al in 1975. The  lignan lactones could be distinguished by their  
characteristic fluorescent colour. Diphyllin ( violetish blue), Cleistanthin A was 
(blue), Cleistanthin B (greenish blue )and collinusin ( green )(K.S Annapoorani, 
PhD Thesis). All colours were stable for many days except diphyllin. Also, it was 
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observed that the sequence of appearance of the colours was different in different 
solvent systems. This method is highly sensitive. 
High performance liquid chromatography was used to confirm the purity of the 
compound. The fractions can be characterized with Liquid chromatography/Gas 
chromatography – Mass Spectrometry (LC-MS/ GC-MS). Structural 
characterization can be done using various spectroscopic tools that include 
1H/13C-NMR, 2D NMR, FT-IR and high resolution mass spectroscopy. 
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INTERESTING FACTS ABOUT ODUVAN FROM OUR LAB 
Though many of the active constituents in C.collinus have been identified and 
purified and chemical structures known, they are not available commercially. 
Though some companies sell synthesized compounds, the costs are excessive 
(about $500 for 20 mg). The Dept of Physiology at CMC, Vellore has many 
research questions being pursued regarding the toxicity of C.collinus and even to 
meet the demands of our department, we have not been able to procure either 
Cleistanthin A or other toxins commercially. When Cleistanthin B was procured 
from a Chinese company which was the only one to respond to a request placed 
on the internet, the item turned to be a hoax. Extensive research regarding 
Oduvanthazhai is happening in our department for the last ten years. As part of a 
Ph.D Thesis (unpublished data ),  
 1. Different types of aqueous extracts were prepared from 100 grams of  fresh or 
dried leaves and compound profiling was done. They are as follows: 
 a)  Hexane delipidated leaves 
i.Boiled extract 
ii.Room temperature extract (24hours of soaking) 
iii.Room temperature extract(24 hours of soaking) boiled later 
  b ) Shade dried leaves 
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i.Boiled extract 
ii.Room temperature extract ( 24hours soaking) 
iii.Room temperature extract(48 hours soaking) 
iii.Room temperature extract (24 hours) boiled later 
 c ) Fresh leaves 
i.Boiled extract 
ii.Room temperature extract (24 hours of soaking) 
iii.Room temperature extract (48 hours of soaking) 
iii.Room temperature extract boiled later 
iv.Fresh leaf ground extract 
2.Simple method for isolation and quantification of cleistanthins and Diphyllin 
from cleistanthus collinus leaves was established. Liquid/Liquid partition 
chromatography of aqueous extracts with chloroform to isolate fluorescent 
compounds  was started. Traditionally, these compounds were isolated from 
acetone extracts of dried and delipidated leaves with column chromatography. 
The methods required extensive use of solvents such as n-hexane, benzene 
(known to be highly toxic, and therefore banned from countries like Australia) 
and ethyl acetate We have developed easy methods of purification of these 
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compounds from the aqueous extract with thin layer chromatography, without the 
use of Benzene or ethyl acetate (As part of a Ph. D Thesis). 
 3. Quantification of fluorescent compounds in different extracts was done by 
High performance liquid chromatography  in collaboration with clinical 
Pharmacology Unit of our own institute. (As part of a Ph. D Thesis). 
4. After extensive quantification experiments, we short-listed the best type of 
aqueous extract that provides large quantities of a given fluorescent compound (As 
part of a Ph. D Thesis). 
5. Short-listed aqueous extracts are used to isolate a particular fluorescent 
compound (identified in HPLC) in large amounts for mechanistic studies on 
animals. (As part of a Ph. D Thesis). 
6. Structure of the isolated compounds with Thin layer chromatography was 
characterized with Mass Spectrometry, NMR spectrum (NOSEY, COSEY and 
HMPC), Infrared spectrum, melting point analysis in collaboration with 
Chemistry department of IIT, Mandi. (As part of a Ph. D Thesis). 
 7. Established an animal model of C.collinus poisoning:  
Boiled whole aqueous extract was administered to the rats, there was a type I 
distal renal tubular acidosis due to a possible proton pump inhibition, and there 
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was type II respiratory failure. In vitro studies on the renal brushborder 
membrane and basolateral membrane showed  V-type ATPase blockade, causing 
DRTA (Maneksh et al.,2010 ) 
We have determined the clinical profile of toxicity by administering following extracts 
intraperitoneally into the rats. 
8. Cleistanthin A  from hexane delipidated acetone derived boiled extract was tested in 
vivo by injecting it intraperitoneally in rats. Rats died due to sudden respiratory arrest 
followed by cardiac arrest (Dr. S. Anitha, M.D Thesis, 2010).
 
9.Cleistanthin B when tested in vivo showed toxicity. The rats died with respiratory arrest 
followed by cardiac arrest administration (Dr. Rajam, M.D. Thesis, 2011).  
10. Diphyllin, when tested in vivo, did not kill the rats upto 8 hours after administration 
(Dr. Latha, M.D. Thesis, 2011).
 
 Hence, Diphyllin is the only known  non toxic fluorescent component of 
cleistanthus collinus. 
11. NFF (non-fluorescent fraction)  was found to be non toxic when administered 
intraperitoneally (Dr.Swetha,MDThesis.,2014)  
12. Proton channel modulating activity of whole aqueous extract, Cleistanthin A, 
Cleistanthin B have been tested by patch clamp technique on neutrophils. 
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It was found that the whole aqueous extract blocked proton channels, while Cleistanthin 
A and Cleistanthin B did not affect the conductance. (This issue of proton channel 
blockade is very important because there is no known proton channel blocker except 
zinc). It blocked the voltage gated sodium, calcium and delayed rectifier potassium 
channels, hence proved to be a non specific cation channel blocker (Dr. Praghalathan 
Kanthakumar, M.D Thesis 2010). 
However it was found later that the whole aqueous extract contains significant amount of 
zinc, which is a known proton channel blocker. Drum stick leaf extract which contains 
equal amount of zinc also blocks the proton channel. Therefore this line of investigation 
has been discontinued temporarily. Hence, the active principles were extracted by 
adsorption chromatography to test them individually. 
Patch clamp studies on proton channels in neutrophils showed that, the proton 
current densities increased due to Cleistanthin A. (Dr. R.Rajalakshmi, M.D Thesis, 
2012). Cleistanthin B was tested in patch experiments and it was seen that it did 
not block proton channels of neutrophils (G.Gnanasenthil, M.D Thesis, 2012). 
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Aim 
The aim of the present study was to develop an antidote for Cleistanthus collinus 
poisoning. 
 
                                     Objectives 
(1)To determine the minimum lethal dose of boiled water extract of C.collinus 
when administered orally. 
(2) To see if a particular fraction of Cleistanthus collinus extract (non fluorescent 
fraction of cold water extract, NFF) can prevent death in rats when administered 
after administering the lethal dose of boiled water extract. 
(3) To determine the minimum lethal dose of pure Cleistanthin C when given 
orally. 
(4) To determine if non fluorescent fraction of cold water extract of C.collinus can 
prevent death in rats poisoned with lethal dose of Cleistanthin C. 
(5) To determine the minimum lethal dose of  fresh leaf ground extract when given 
orally. 
(6) To determine the minimum lethal dose of pure Cleistanthin A when given 
orally. 
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It is a known fact that mortality is higher when boiled decoction of the leaves is 
consumed, as against crushed leaves. Parallel work in our lab led to the 
observation that the boiled extract contains cleistanthin C while the room 
temperature extract does not. The logical assumption at first was that cleistanthin 
C can be extracted only by boiling. However, when the leaves were soaked in 
water in room temperature for 24 hours were then boiled, Cleistanthin C was still 
not found in the extract. The hypothesis, then was that exposure to tepid water 
destroys Cleistanthin C while boiling without exposure to tepid water preserves 
Cleistanthin C. This led us to hypothesize that there may be a heat labile substance 
in cleistanthus collinus leaves which can destroy Cleistanthin C. This may be 
probably an enzyme. 
 
 
Cleistanthin C + Putative Enzyme                       Cleistanthin C concentration   
Increases 
                                      Boiling destroys the Enzyme 
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Cleistanthin C + Enzyme                      Cleistanthin C concentration decreases 
                                         Tepid Water  
Cleistanthin C + Enzyme             cleistanthin C concentration decreases          
                                       Tepid water                                    
                                                                                          Boiled further 
                               Slight increase in concentration ;but lower concentration 
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Figure 6 : Thin layer chromatogram of boiled, room temperature (RT) and 
room temperature boiled extracts (RTB) of Fresh leaves of C.collinus.  
Lane1 : Boiled extract  
Lane 2 : Room temperature extract  
Lane 3 : Room temperature boiled extract. 
Notice that in lanes 2 and 3, Cleistanthin C fluorescence is absent where as in lane 
1 shows Cleistanthin C fluorescence (Boiled). 
If indeed there was neutralization of Cleistanthin C by an enzyme during room 
temperature extraction, accounting for the observations discussed so far, then we 
reasoned that ice cold extraction may disallow enzyme action and Cleistanthin C 
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would be present in the ice cold extract. As expected, Cleistanthin C is detected in 
aqueous extracts with ice cold water. 
The enzyme being water soluble, would not dissolve in organic solvents. Any 
extract made with organic solvents should therefore contain Cleistanthin C. 
We expected that this putative enzyme will elute only in aqueous extracts and that 
when the aqueous extract is partitioned with chloroform (see method section), the 
putative enzyme will remain in the water fraction. Therefore we took ice cold 
water extract (ICWE) which would contain  the enzyme intact (but without 
optimal temperature for its activity) and removed all the fluorescent compounds 
(which include toxins) with chloroform partitioning. The toxins went into 
chloroform. The remaining water part of the ice cold extract, we hypothesized, 
would contain the enzyme which degrades the Cleistanthin C and be devoid of 
toxins. 
Our research question was if this fraction would serve as an antidote for 
Cleistanthus colllinus poisoning. A good part of thesis was devoted to preparation 
of extracts, standardization of toxic dose of Fresh leaf boiled extract (FLB), 
standardization of toxic dose of cleistanthin C and determination of non toxicity of 
the non-fluorescent fraction of the ice cold water extract ( NFF OF ICWE) which 
was to serve as the antidote. Corroborative evidence that NFF of ICWE destroys 
Cleistanthin C is provided as chromatograms. Pilot studies were performed to test 
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effect of the probable antidote in fresh leaf boiled extract poisoning and 
cleistanthin C poisoning. 
 
Figure 7 : Thin layer chromatogram of boiled extracts prepared from shade dried 
and fresh leaves incubated with two different type of non fluorescent fractions 
(FLICWE & FLICBWE ). 
Lane 1 :SHB- shade dried boiled,  Lane 6 :FLB- Fresh leaf boiled extract. 
Lane 2 :FLICWE-Fresh leaf ice cold water extract (NFF of FLICWE) 
Lane 4 :FLICBWE- fresh leaf ice cold boiled extract (NFF of FLICBWE) 
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As we see, in lane 3 and 7 boiled extracts when incubated with non 
fluorescent fraction of ice cold water extract, cleistanthin C fluorescence 
disappears. On the contrary, boiled extracts incubated with non fluorescent 
fraction of ice cold boiled extract , which is devoid of enzymatic activity due 
to boiling ,there is no quenching of Cleistanthin C fluorescence.  
The conclusion therefore is that Cleistanthin C destroyed by an enzyme, also 
present in the leaves, when the two (Cleistanthin C and the enzyme ) come into 
contact with each other, which happens when the leaves are soaked in water at 
room temperature. This may be the reason why crushed leaves or room  
temperature extracts are not as lethal as boiled extracts in humans. Toxicity studies 
may now focus on Cleistanthin C because it seems to be the major lignan in fresh 
leaves. It remains to be seen if the putative enzyme in C.collinus  leaves that can 
destroy Cleistanthin C could serve as an antidote to C.collinus poisoning. 
Quantification studies showed that boiled water extract contains a large amount of 
Cleistanthin C in addition to Cleistanthin A and at low concentration in fresh leaf 
water ground extract which further supports our hypothesis. 
In previous experiments done in our lab, toxins were administerd intraperitoneally 
which may be the reason why the clinical picture does not match the human 
condition exactly. However, the experiments have helped us to understand the 
 57 
 
electrolyte and ABG profiles during the course of the toxicity. However, we now 
realize that it is important to develop an animal model of the poisoning which 
mimics human cases so as to study treatment options. 
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EXPERIMENTAL DESIGN 
A boiled decoction of C.collinus was made in a way patients normally prepare it. 
Leaves were added to water and then boiled for 10 minutes. The decoction was 
filtered and dried. To isolate cleistanthin C and A, cooled decoction was subjected 
to liquid liquid partition chromatography with chloroform. The top water fraction 
was devoid of fluorescence and therefore termed as the non fluorescent fraction or 
NFF.  The bottom chloroform fraction (CF) had sequestered all fluorescent 
compounds, concentrated and dried to a powder. The three major active priniciples 
Cleistanthin A, C and diphyllin was separated by TLC on silica gel plates. 
Cleistanthin C  and A was purified further for animal studies.Fresh leaf ground 
extract was also prepared and minimal lethal dose for the same was estimated to 
see if any gross difference in lethal dose from fresh leaf boiled extract of 
C.collinus . 
Toxicity studies were performed with oral administration of boiled decoction and 
Cleistanthin C. The minimum toxic dose (causing 100 % mortality) of the water 
decoction of fresh leaves of C.collinus and toxic principle, Cleistanthin C was 
determined. After estimating lethal dose for the above mentioned extracts, non 
fluorescent fraction considered to have antidote action was administered to the 
poisoned  rats. The mortality rate was assessed. 
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Materials Required For Extract Preparation 
 
Leaves: Oduvanthazhai  leaves  
Solvents Used 
i. n-Heptane ( SRL) 
ii. Chloroform ( Fisher scientific ) 
iii. Methanol ( ExcelaR ) 
iv. Ethanol AR 99.9%  ( Hayman ) 
For Isolation And Quantification Of Compounds 
1. Liquid/Liquid chromatography 
Separating funnel, standard flask, Glass beakers, petri dishes, funnels, 
borosilicate- proccured from science house. 
2. Thin layer chromatography 
Silica gel-G (contains 13% calcium sulfate as a binder) from Fisher Scientific. 
Glass plates, TLC tank with lid, and spreader from Science house. 
3. Solvent recovery 
Rotary evaporator (Evator from Science house) connected to vaccum pump, 
circulating water bath (equitron from Science house). 
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4. Exhaust fume hood  
5. Hot air oven for drying ( Science house ) 
6. UV illuminator (Toshiba )  
7. High-performance liquid chromatography (HPLC) 
a. Instrument Name :  Shimadzu (HPLC)                                                               
Column  :   Supelco HPLC column, Discovery® HS 
C(18) 
b. Size   :  25cm x 4.6mm, 5µm 
c. Detector  :  RF10 AXL- Fluorescence detector 
8. Lyophylizer for freeze drying 
                     Materials Required For Animal Experiments 
For Oral gavaging: 
Oral feeding tube of size F-15 
Miscellaneous: 
1cc and 5cc syringes 
Hand gloves and apron 
Eppendorffs-.5ml, 1ml 
Extracts used 
1. Fresh leaf boiled aqueous extract 
2. Fresh leaf ground extract 
 62 
 
3. Cleistanthin A 
4. Cleistanthin C 
5. NFF of C.collinus 
Preparation of Fresh leaf boiled extract of C.collinus  (FLB extract)  
Cleistanthus collinus leaves were collected from Amirthi hills, Tiruvannamalai 
district, Tamilnadu, India. 100 grams of fresh leaves was added to 3 litres of 
boiling water , then boiled for 10 minutes. The crude solution was filtered and the 
filtrate was  dried at 37ºdegree celsius to get a dry powder and residue was 
preserved. The extract was scraped out using a scalpel and the powder was  stored 
in bottles at -20 degree Celsius. The boiled decoction was referred to as FLB 
(fresh leaves, boiled). Desired doses of dried powder of C.collinus extract 
dissolved in distilled water were administered to the rats by oral gavage for 
toxicity studies. 
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                          Figure 8 : Preparation of fresh leaf boiled extract 
Identification, characterization and quantification of fluorescent compounds in the 
boiled aqueous extract of Cleistanthus Collinus leaves was done using different 
established techniques, namely,  thin layer chromatography (TLC), nuclear 
magnetic resonance spectroscopy (NMR) and high performance liquid 
chromatography (HPLC). Details of the above mentioned techniques will be 
discussed later. 
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Preparation of fresh leaf ground extract ( FLG ) of Cleistanthus collinus 
 For fresh leaf juice, 100 gm of fresh leaves were ground in 1 litre of water using 
an electric blender and the blend filtered. The filtrates were centrifuged and 
supernatant was collected. The crude solution was filtered and the filtrate was  
dried  to get a dry powder and residue was preserved. The extract was scraped out 
and stored in bottles at -20 degree Celsius. The extract was referred to as FLG 
extract.  
Isolation and Characterization of Cleistanthin C and A 
Isolation of the toxic principles to purity is important for mechanistic studies on 
toxicity  and for development of antidotes.  
Liquid/Liquid partition chromatography 
500  ml  of chloroform  was  added  to  the  filtered boiled decoction  for  liquid 
liquid partitioning (LLP). The immiscible water and chloroform fractions  were 
separated  using  a  separating  funnel.  LLP  was repeated twice with smaller 
volumes of chloroform.  
All the fluorescent compounds in the aqueous extract sequestered in the 
chloroform fraction, henceforth called the chloroform fraction ( CF ). The water 
fraction after LLP was devoid of fluorescence and was termed as non fluorescent 
 65 
 
fraction (NFF).  Chloroform  was  removed  from  CF  with  a  rotary evaporator, 
the concentrate dried to a powder in an oven or on a hot plate and weighed. The 
chloroform recovered during the process was used for further extractions.  
 
                     
 
Figure 9 : Liquid liquid partitioning 
Chloroform layer with 
all the fluorescent 
compounds 
 
 
ounds 
Top Aqueous layer  
 66 
 
 
Figure-9 Liquid/Liquid Chromatography (a) Separating funnel showing two 
immiscible layers. Top aqueous and bottom Chloroform layer.(b) Separated 
aqueous and Chloroform fractions of boiled aqueous extract. 
 
                      
 
               Figure 10 : Shows aqueous extract kept for drying on hot plate. 
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                 Figure 11 : Whole extract and dry powder of the same extract. 
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Figure 12 : Rotary evator was used to recover chloroform from chloroform 
fraction.  
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Preparatory Thin Layer Chromatography 
100 mgs  of  CF powder was dissolved  in chloroform and chromatographed on 
silica gel layered plates.  These  plates  were  then  placed  in  a  solvent  system 
containing mixture of  n-heptane-chloroform-ethanol in the ratio 50:50:10 
(preparatory TLC).  Solvent migration was allowed upto a convenient height 
(about 10 cms) in  an  ascending  manner.  The  plates  were  then  air  dried  and 
viewed under short wave ultraviolet light (352 nm). The band corresponding  to  
cleistanthin A & C  were  scraped off separately and crude cleistanthin C was 
eluted from silica with  methanol  and  the eluted material was dried to obtain 
Cleistanthin  C. Cleistanthin C was purified further by a second thin layer 
chromatogram with chloroform: methanol in the ratio 90:10 and processed further. 
Cleistanthin A was also purified further for toxicological studies. The  compounds  
obtained  were weighed for quantification.The compound isolated was 
characterized with mass spectra, 2D NMR spectra and melting point analysis. 
After the confirmation of structure with spectral methods, reverse phase HPLC 
was performed  to test the purity of the isolated compound. 
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Techniques in detail 
Thin Layer Chromatography 
Thin layer chromatography (TLC) method was used to analyze the compounds 
present in the extract and to isolate them for further purification steps. The sample 
to be chromatographed was spotted on a TLC plate made with silica gel as the 
stationary phase. 35gms of Silica gel was mixed with 70ml of distilled water (1:2 
ratio) to form a mixture. Then the slurry was poured in the spreader and the silica 
gel was applied over the glass plates ( 0.5mm thickness ).After natural drying the 
plates were activated by keeping in an oven at 110°C for 30 minutes.  
                 
 
 Figure-13 TLC glass plates were coated with the silica gel using spreader 
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Whole aqueous extracts, chloroform and aqueous fractions of the aqueous extracts 
were chromatographed. Powder form of both whole aqueous extract and aqueous 
fraction after partitioning were dissolved in water whereas chloroform extract was 
dissolved in chloroform at a concentration of 1mg /10µL  and 5 µl of these 
samples were spotted with the help of capillary tubes on the TLC plates. The TLC 
plates were placed in a TLC tank, containing a mixture of solvents namely n-
heptane , chloroform and ethanol in the ratio 50:50:10 (Fig-2). When the mobile 
solvent front rises up by capillary action, highly polar solutes remains at the initial 
spot whereas, the less polar solutes were carried upwards with the mobile phase. 
Once solvent front reaches the top of the plate, the TLC was stopped.  
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Figure 14 : Demonstrates TLC-tank with plates spotted with sample placed in 
solvent tank .  
The plates were then visualized under Ultraviolet  light in 352nm(Fig-15). The 
fluorescent compounds were seen as bands under the UV light. The non 
fluorescent compounds were not visible under UV light.  
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                                                    Figure -15: UV box 
 
 
TLC results were interpreted in terms of Retardation factor (Rf value) which is the 
ratio of distance moved by the compound from the point of application to the 
distance moved by the solvent front from the point of application .The bands 
corresponding to Cleistanthins A & C and Diphyllin were marked and collected 
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based on the known Rf values for each of these compounds. The eluted material 
was dried and the compounds obtained were weighed for quantification.  
                                  
 
Figure-16 Thin layer chromatogram of fresh leaf boiled extract shows three 
prominent fluorescent bands of Cleistanthin-A, Diphyllin and Cleistanthin C in 
sequence from top to bottom. 
In TLC, the compound with Rf value 0.34 as same as reported by K.S 
Annapoorani migrated similar to an authenticated sample of Cleistanthin A 
obtained from Godavari . 
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Figure 17:  demonstrates that the fluorescent compound with Rf value 0.34 
obtained by us migrates similar to an authenticated sample of Cleistanthin A 
provided by Godavari Biorefineries in TLC performed with Chloroform-n-
heptane-ethanol (50:50:5). Rf stands for retardation factor .                                                      
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High Performance Liquid Chromatography ( Clinical Pharmacology 
Unit, CMC Vellore). 
In preparatory thin layer chromatography, fluorescent bands corresponding to the 
reported Rf values were collected and purified further. The purity of the 
compounds were checked with HPLC .   
Reverse phase HPLC using C18 columns (Supelco HPLC column, Discovery® 
HS C(18) of size 25cm x 4.6mm, 5μm particle size) were used in a Shimadzu 
HPLC system with a fluorescent detector. Excitation and emission wavelenghts 
were  λexc 320 nm and λemis 450 nm respectively.  
The major fluorescent compounds which were isolated by preparatory TLC ( 
Cleistanthin C and Cleistanthin A) were dissolved in ethanol at different 
concentrations (10, 20, 30 and 40 μg/ml for the cleistanthins) and loaded in the 
column to elicit HPLC chromatograms. The mobile phase was 70 % methanol. 
With “Area Under Curve” (AUC) for each concentration, standard curves were 
constructed (AUC versus concentration).  
Chloroform fraction (CF) obtained from FLB was subjected to HPLC to (i) 
identify and (ii) quantify the major peaks detected by a fluorescence detector as 
these peaks were likely to be the major active principles in the respective extracts. 
The concentration of CF of the extracts used was 50 or 100 μg/ml. 
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The concentrations of the compounds in CF of  fresh leaf boiled extract was 
calculated using the HPLC standard curves. Then, the amount of compound 
present in the extract from 100 gram leaves was calculated from the total weight of 
CF obtained from the boiled extract.  In addition, the compounds separated by 
preparatory TLC from FLB was weighed to see if the weights matched the HPLC 
quantification, after allowing for reasonable losses during the TLC. 
Chemical characterization of Cleistanthins A and C was performed at 
IIT Mandi.   
Cleistanthin C and Cleistanthin A were thoroughly characterized using various 
spectroscopic tools that include 1H/13C-NMR, 2D NMR, FT-IR and high 
resolution mass spectroscopy. Though some characterization data for these 
compounds were available, they were not in detail. The 2D NMR spectra for Cle C 
were too complicated and therefore acetate derivative of Clei C was prepared 
which indeed showed much simpler spectra than its parent molecule.  
X-ray Crystal Structure Analysis of Cleistanthin A  ( IIT Mandi ) 
Colourless needle shaped crystals of Cleistanthin A suitable for single-crystal X-
ray diffraction analysis were obtained from slow evaporation of diethyl ether 
solution after 2 days. Data collection was done using CrysalisPro Software and 
reduction was undertaken with CrysalisPro Software. The structure was solved by 
direct methods using olex
2
, SHELXS-97 and refined by full-matrix least squares 
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on F
2
 using SHELXL-97. The positions of all the atoms were obtained by direct 
methods. 
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TOXICITY EXPERIMENTS 
The primary goal was to find out the minimum dose of the following extracts 
which results in 100 % mortality. Experiments were designed in such a way that it 
mimics the patient scenario who comes with history of oduvanthazhai poisoning.  
Extracts used                 : Fresh leaf boiled extract, cleistanthin C 
Route of administration : Oral and Intraperitoneal routes 
Methods used                 : Oral gavage with feeding tube 
Mode of Anaesthesia     :  Inhalational, chloroform was used 
Observational Period      :  2 weeks 
Parameter assessed         :  Mortality rate 
Animals Used 
Wistar rats weighing between 120 and 150grams were used. The rats were  housed 
at the institutional animal housing facility in Christian medical college, Vellore 
under adequate conditions. Animals were fed with food and water ad 
libitum.Experimental protocol was approved by the Institutional Animal Ethics 
Committee. All animal experiments were done in accordance with the guidelines 
of the CPSCEA,India.  
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DETERMINATION OF LETHAL DOSE OF FRESH LEAF BOILED 
EXTRACT OF C.COLLINUS 
Wistar rats were starved for 4 – 6 hours prior to the experiment.They were housed 
in different cages in groups of four. For toxicity studies, anesthetized rats were 
administered different doses of FLB extract dissolved in water  by oral gavage and 
returned to their cages. Afterwards rats had access o food and water ad libitum. 
The animals were closely monitored for any kind of distress or any abnormal 
behaviour after intervention. Four rats in a group were used per dose and the 
different concentrations used were 100, 75, 50 and 25mg/100 gram bodyweight of 
the rat. Toxic doses killed the rats in 14 -18 hours duration. In the case of 
survivals, were observed for 2 weeks to decide if the administered fraction caused 
death or not. Approximate minimum lethal doses were determined for the whole 
extract using minimum number of animals. The procedures were approved by the 
institutional animal ethics committee.  
 
DETERMINATION OF LETHAL DOSE OF FRESH LEAF GROUND 
EXTRACT OF C.COLLINUS 
Different concentrations used were 25 and 50mg/100 gram body weight of the rat. 
The animals were closely monitored for any kind of distress or any abnormal 
behaviour after intervention and they will be housed for a duration of two weeks 
time. 
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DETERMINATION OF LETHAL DOSE OF CLEISTANTHIN C 
ISOLATED FROM  C.COLLINUS EXTRACT 
Cleistanthin C of various concentrations was administered and observed for a 
specified period.Oral gavage was employed to administer the toxin and looked for 
any immediate post interventional complications.Dose concentrations of 1, 2, 3 
and 4 mg/100grm body weight were given. Another set of four rats was used for 
each dose to determine the minimal lethal dose of cleistanthin C which results in 
100% mortality.  
 
DETERMINATION OF LETHAL DOSE OF CLEISTANTHIN A 
ISOLATED FROM  C.COLLINUS EXTRACT 
As mentioned above, the same method was followed for Cleistanthin A also.  
Dose concentrations of 1, 3 and 4 mg/100grm body weight were given via oral 
gavage. Animals were observed for a period of two weeks. 
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"Investigation on non-fluorescent fraction (NFF) of  
cold water extract of Cleistanthus collinus leaves as an 
antidote to Cleistanthus collinus" 
 
Preparation of non fluorescent fraction ( NFF ) extract of  C.collinus  
 NFF to be tested as an antidote was  prepared from fresh leaf ground water 
extract.  Ice cold water was used instead of  tepid water to preserve the action of 
the enzyme (putative anti C enzyme).100 grams of  fresh leaves was ground in 1 
litre of  ice cold water using an electric blender to get a thick concentrate. To be 
precise, NFF was prepared from fresh leaf ground ice cold water extract( 
FLGICWE ) so as to preserve its enzymatic nature if at all present. The crude 
material was centrifuged at 2400rpm for 20mins, filtered and transferred to glass 
beaker . Filtered extract was partitioned with chloroform immediately. As 
explained earlier, two immiscible layers were separated using separating funnel 
and fraction of  concern, top water fraction called as non fluorescent fraction was 
collected  in  glass vials. Clearing step with chloroform was repeated many times 
to make sure that, the extract collected is devoid of all fluorescent compounds. 
During  all the processing steps, care was taken to maintain cold temperature. 10 
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ml glass vials were filled with 5 ml filtrate and  stored in -20 degree Celsius deep 
freezer prior to lyophilization .  
 
 
            
 
  
Figure 18 : Fresh leaf ice cold ground extract before  and after centrifugation 
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Figure 19 : LLP 
Once samples are frozen, they were transferred to lyophilizing machine, kept aside 
for 24 hours to get fine powder of the extract. Leaf extract was weighed and stored 
in refrigerator for future use.  
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Figure 20: Freeze dryer / Lyophylizer    
   
  Figure 21 : Lyophylized powder                          
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Thin layer chromatography was done to confirm that, the non fluorescent fraction 
of cold water extract was free from all known toxic cleistanthins.   
 
                   
 
Figure 22: Thin layer chromatogram of fresh leaf ground extract of C.collinus . 
From left to right-  
Lane 1: Fresh leaf ground whole extract before partitioning (FLG)  
Lane 2: chloroform fraction of ground extract (FLG-CF)  
Lane 3: water fraction of ground extract after chloroform partitioning (FLG-NFF). 
Water fraction after chloroform partitioning( lane 3) do not have fluorescence.  
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EXPERIMENTAL PROTOCOL TO TEST IF NON FLUORESCENT 
FRACTION CAN BE AN ANTIDOTE IN C.COLLINUS POISONING 
SET 1 EXPERIMENTS - FRESH LEAF BOILED EXTRACT + NFF  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Lethal dose of boiled aqueous extract of 
C.collinus was administered to rats by oral  
100mg/100gm of NFF of 
C.collinus was given to the 
poisoned rats after one hour. 
Observed for 2 weeks; mortality 
rates were assessed 
Lethal dose of boiled aqueous extract of 
C.c llinus(75 mg/100gm ) was 
administered to rats by o al gav ge. (n=3) 
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SET 2 EXPERIMENTS – CLEISTANTHIN C + NFF 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Lethal dose of Cleistanthin C  
( 4mg/100gm) was administered via oral 
gavage ( n=3 ) 
100mg/100gm of NFF of  C.collinus 
was administered to the poisoned rats 
after one hour. 
Observed for 2weeks; mortality rates 
were assessed. 
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To prove the non lethality of non fluorescent fraction itself, rats were administered orally 
200 mg of NFF per 100 gram body weight (n=2) and 5mg/100 GM (n = 2) 
intraperitoneally and observed for a period of 2 weeks. 
In order to study the role of NFF, the same was administered to the rats poisoned 
with a lethal dose of boiled extract (75 mg /100 gm ) or cleistanthin C (4 mg/ 
100gm ). More than 95 % dose of NFF was administered orally and animals were 
returned to the cages, closely monitored for a period of two weeks (n = 3 in each 
group). Maximum volume administered intraperitoneally was  0.3 ml at a time.  
Mortality rate and time to death was recorded.  
The dose required to prove the antidote effect of non fluorescent fraction was not 
standardized due to various reasons. Main reason  being  no previous studies based 
on this concept. Secondly, intraperitoneal route was the chosen method of 
administration, but the final calculated dose was dissolvable only in relatively a 
large volume of solvent. The high volume after reconstitution was difficult to 
inject.   
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RESULTS 
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RESULTS OF LETHAL DOSE ESTIMATION OF DIFFERENT 
EXTRACTS  AND COMPOUNDS ISOLATED FROM CLEISTANTHUS 
COLLINUS 
1. Minimal Lethal dose Estimation of Fresh Leaf Boiled 
Extract of Cleistanthus collinus  
 
 
 
Figure 23: Graph shows minimal lethal dose ( LD 100 ) of fresh leaf boiled 
extract of cleistanthus collinus ( n = 4). 
( x axis – dose concentration in mg /100 gm, y axis – mortality rate ) . 
0% 
25% 
50% 
75% 
100% 
25 50 75 100 
50% 
75% 
100% 100% 
M
o
rt
al
it
y 
ra
te
 
Dose concentration of FLB extract in mg / 100 gm body weight 
n = 4 
 92 
 
2. Minimal Lethal dose Estimation of Fresh Leaf Ground 
Extract of Cleistanthus collinus 
 
 
Figure 24 : Graph shows minimal lethal dose ( LD 100 ) of fresh leaf ground 
extract of cleistanthus collinus ( n = 4). 
( x axis – dose concentration in mg  /100 gm, y axis – mortality rate ) . 
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3. Minimal Lethal dose Estimation of Cleistanthin C 
 
 
Figure 25: Graph shows minimal lethal dose (LD 100 )of Cleistanthin C ( n = 4). 
( x axis – dose concentration in mg/100gm, y axis – mortality rate ) . 
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4. Minimal Lethal dose Estimation of  Cleistanthin A 
 
 
 
Figure 26 : Graph shows minimal lethal dose ( LD100 ) of Cleistanthin A ( n = 4). 
( x axis – dose concentration in mg/100gm, y axis – mortality rate ) . 
 
0% 
25% 
50% 
75% 
100% 
1 3 4 
75% 
100% 100% 
M
o
rt
al
it
y 
ra
te
 
Dose concentration of Cleistanthin A in mg / 100gm body weight. 
n = 4 
 95 
 
The minimum lethal dose causing death in all animals for the toxic fractions tested 
is given in table 1. 
Table 1: Lethal doses in rats per 100 gm body weight is summarized below: 
 
 
         Fraction tested 
 
 
LD 100 Dose 
         ( n =  4 ) 
 
 
LD 75 Dose 
     ( n =  4 ) 
 
 
LD 50 Dose 
( n =  4 ) 
 
 
Non 
lethal 
dose 
( n =  4 ) 
 
 
 
Fresh leaf boiled 
extract 
(FLB) 
 
 
 
           75 mg 
 
 
 
50 mg 
 
 
 
       25 mg 
 
 
 
        - 
 
 
  Fresh leaf ground 
extract 
                 (FLG) 
 
 
50 mg 
 
 
- 
 
 
25 mg 
 
 
- 
 
 
 
Cleistanthin C 
 
 
 
3 mg 
 
 
 
- 
 
 
 
2 mg 
 
 
 
1 mg 
 
 
 
Cleistanthin A 
 
 
 
          3 mg 
 
 
 
1 mg 
 
 
 
- 
 
 
 
- 
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Results of the study on the antidote effect of non fluorescent 
fraction of cold water extract of cleistanthus collinus 
1. Cleistanthin C +  Non fluorescent fraction of cleistanthus collinus 
 
Figure 27: Graph shows the effect of NFF on Cleistanthin C poisoned rats ( n = 
3).( x axis – dose concentrations in mg /100gm body weight, y axis – mortality 
rate ) . 
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2. Fresh leaf boiled extract + Non fluorescent fraction of 
Cleistanthus collinus 
 
 
Figure 28: Graph shows the effect of NFF in rats poisoned with fresh leaf boiled 
extract of Cleistanthus collinus ( n = 3). 
( x axis – dose concentrations in mg /100gm body weight, y axis – mortality rate )  
. 
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Doses  upto 200mg/100gm body weight of NFF orally ( n=3 ) was nonlethal.  
100 mg /100 gm body weight of NFF was not adequate enough to save the animal.  
In fresh leaf boiled extract group , even though the mortality rate remains 
unaltered,  time to death was found to be delayed  in one animal (took around 40 
hrs to die  as against 14-16 hrs in other rats poisoned with FLB ).   
In Cleistanthin C administered group, one rat survived out of four rats. 
As shown in the figures 27 and 28 non fluorescent fraction  was  found not to have 
any protective effect on mortality at the dose discussed previously. Therefore, it 
becomes critical to perform  dose standardization for non fluorescent fraction ( 
NFF ) in order to  consider it  for a better outcome. 
Pattern of Death 
Animals that received acute dose of extracts were found to be restless, moving 
around the cage; with progress of time convulsions started which became intense 
and the animals died subsequently.  
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THIN LAYER CHROMATOGRAPHY: COMPOUND PROFILE 
 
Thin layer chromatography was performed in order to demonstrate the difference 
between fresh leaf boiled and fresh leaf ground extracts  of Cleistanthus collinus 
based on cleistanthin C fluorescence. As compared to the cleistanthin C 
fluorescence in fresh leaf boiled extract (Lane 2),  it was observed that  the 
Cleistanthin C fluorescence was almost nil in fresh leaf ground extract (Lane 4). 
Intensity of the fluorescence gives us a clue about concentration of different 
compounds. Chromatogram also provides us an overview about the compound  
profile in the  different extracts of cleistanthus collinus . 
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Figure 29 : Thin layer chromatogram of boiled extract (FLB, lane 1), chloroform 
fraction from boiled decoction (FLB-CF, lane 2), water fraction of boiled 
decoction after chloroform partitioning (FLB-NFF, lane 3), fresh leaf ground 
(FLG, lane 4), chloroform fraction from fresh leaf ground (FLG-CF, lane 5), and 
water fraction of fresh leaf ground extract after chloroform partitioning (FLG-
NFF, lane 6). All the fluorescent compounds partition into chloroform (lanes 2 and 
5). Water fractions after chloroform partitioning (lanes 3 and 6) do not have 
fluorescence. 
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Figure 30 : Percent distribution of fluorescent compounds in fresh leaf boiled 
extract prepared from 100 gms leaves from TLC data . 
 
  
The amount of compound present in the extract from 100 gram leaves was 
calculated from the total weight of CF obtained from the boiled extract.  
Cleistanthin C constitutes the major part of the toxic fraction of fresh leaf boiled 
extract which can be accounted for the toxicity of the extract. 
Diphyllin 
29% 
Clei A 
1% 
Clei  C 
70% 
Diphyllin Clei A Clei B 
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DISCUSSION 
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Cleistanthus collinus poisoning is common in rural south India. Water extract of 
Cleistanthus collinus leaves is a common suicidal poison. Victims consume either 
a boiled decoction (FLB, fresh leaves boiled) or fresh leaves blended and filtered. 
Mortality is about 28% and is stated to be higher with FLB than fresh leaf ground 
extract ( FLG ). 
The leaves contain more than 20 fluorescent compounds(Pinho and Kijjoa, 
2007). It has been documented that Cleistanthin A and B are toxic and cause 
death in rats (Annapoorani, Ph.D Thesis). Two other lignan lactones in aqueous 
extract of C.collinus namely collinusin and diphyllin were shown to be nontoxic 
(Annapoorani, Ph. D Thesis). It is therefore suggested that toxicity of C.collinus 
extract is primarily due to Cleistanthins A and B . We have also made similar 
observations in studies on rats (yet unpublished). However, it is also reported 
that Cleistanthin A and B are not present in the aqueous extracts of C.collinus 
leaves (Subramani et al., 2014.) and that purified Cleistanthin A and B do not 
cause death up to concentrations as high as 800 mg/kg bodyweight in rats 
(Parasuraman and Raveendran, 2012).  
It is considered thus far that Cleistanthins A and B are the toxic principles 
responsible for death. But we found that (a) Cleistanthin B is not present in either 
extract. (b) Cleistanthin C is present in aqueous extract. Concentration of 
Cleistanthin C was very high in FLB, but was negligible in FLG (Unpublished 
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observation from a concurrent Ph. D  Thesis). Whether this difference accounts for 
the higher toxicity of FLB in patients remains to be seen.   
 
In the present  study, toxins present in the clinically relevant C.collinus leaf 
extract, namely the boiled extract was investigated. Apart from boiled extract, 
purified cleistanthin C was also studied after confirming the identity of the 
compound. Toxicity profiles were also investigated.  
 
 The boiled aqueous extract of fresh leaves contains more than 7 fluorescent 
compounds. The identities of the two major fluorescent compounds are confirmed 
as Cleistanthin A, Cleistanthin C undoubtedly with the help of NMR. Apart from 
these known fluorescent fractions ,the identity of other unknown compounds are to 
be explored. NMR was performed in collaboration with chemistry department ,IIT 
Mandi to confirm the compound identity.  
This is the first time that we report cleistanthin C  as a clinically relevant toxin in 
C. collinus extract.  All clinical studies published thus far mention Cleistanthin A 
& B as clinically important toxins. However we were unable to isolate cleistanthin 
C from the aqueous extract. Cleistanthin A & B are monoglycosides while 
cleistanthin C is a diglycoside. In studies where cleistanthin B has been studied for 
toxicity, the compound was isolated from an acetone extract. However we believe 
that, only toxins present in the aqueous extract are clinically relevant as this is the 
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form that  patient consume. So we have focused on only the toxins which elute 
with water extract. The success of our approach in studying the toxins present only 
in water extract is due to a chance finding that chloroform partitioning of the water 
extract sequesters all the fluorescent compounds into chloroform. A previous MD 
thesis from the department (Dr. Swetha, MD.Thesis., 2014 ), found the water 
fraction after chloroform partitoning of aqueous extract to be non toxic. Therefore 
the toxin must occur in chloroform fraction.  
An observation that is stated repeatedly is that fresh leaf boiled extract is more 
toxic than the fresh leaf ground. One objective in our lab was to show fresh leaf 
boiled extract differs from fresh leaf ground extract in terms of fluorescent 
compounds present in the chloroform fraction of water extract. In thin layer 
chromatography, fresh leaf ground does not contain cleistanthin C while fresh leaf 
boiled has it. This could be the reason why fresh leaf boiled is more toxic than 
fresh leaf ground. 
In humans, it is probable that boiled decoction is more poisonous the fresh leaf 
ground extract, because first contains high amount of cleistanthin C.  
However as the results of this study shows, the minimum lethal dose for fresh leaf 
boiled and fresh leaf ground are not very different in rats . 
Quantification experiments done by a Ph.D student in our department (Synopsis 
submitted) show that cleistanthin C is the predominant lignan present in boiled 
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aqueous extract of Cleistanthus.collinus. Weights of cleistanthin A in Chloroform 
fraction of fresh leaf boiled extract were negligible. Based on the quantification 
done as part of the Ph.D thesis, I have estimated the probable weights of pure 
compounds present in minimum lethal doses of FLB and FLG. The estimated 
weights are given in table 2. 
Table 2: Calculations for probable amounts of each of the three studied 
compounds in minimum lethal doses of aqueous extracts from HPLC data: 
Minimum lethal 
dose for whole 
leaf extracts for 
100 g BW 
Compound 1 Cleistanthin C Cleistanthin A 
FLB 75 mg < 0.03 mg 9.6 – 10.3 mg 0.16 – 0.26 mg 
FLG 50 mg 0.02 – 0.08 mg 0.23 – 0.61 mg 0.23 – 0.6 mg 
 
 
 107 
 
The major observations in this table are that the fresh leaf juice is as poisonous as 
the boiled decoction in rats. Even if species differences can be attributed to 
difference in humans and rats it still remains to be investigated as to why fresh leaf 
ground extract is toxic in rats. As shown in table 2,,the amount of cleistanthin C 
present in minimum lethal dose of fresh leaf boiled extract is considerable. It is 
infact double that of minimal lethal dose of cleistanthin C. Therefore all toxicity of 
fresh leaf boiled extract in rat can be attributed to cleistanthin C. However the 
amount of cleistanthin C in  minimal lethal dose of fresh leaf ground extract is 
lower than non lethal dose of cleistanthin C.therefore cleistanthin C cannot be the 
toxin in FLG. Even the amount of cleistanthin A in minimal lethal dose of  of FLG 
is extremely low and cannot account for the high toxicity of FLG in rats. 
Therefore we conclude that, the toxicity of fresh leaf ground is neither due to 
cleistanthin A or C , but due to a yet unidentified compound. 
In this study, we hypothesized that this water fraction (NFF) from the room 
temperature extract may contain an enzyme that destroys cleistanthin C (See study 
rationale). The experimental scheme was to use this fraction as an antidote in pure 
cleistanthin C poisoning and in poisoning with fresh leaf boiled extract which 
contains large amount of cleistanthin C. 
The table below summarizes the LD50 and LD100 data for various fractions of 
C.collinus extracts as reported by K.S.Annapoorani (Annapoorani, Ph.D Thesis.) 
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Table 3: 
Extract or fraction Species Route of 
administration 
LD50 
gm/kg 
LD100  
gm/kg 
Whole aqueous 
extract (Boiled ) 
Wistar rats Oral 10.5 ± 1.25 13 
  Intraperitoneal 2.5 ± 0.75 4.5 
  Intravenous 2 ± 0.5 3.3 
     
Cleistanthin B Wistar rats  mg/kg mg/kg 
  Oral 10.0 ± 1.25 12.5 
  Intraperitoneal 1.8 ± 0.48    4 
  Intravenous 1.5 ± 0.6    3 
 
Sarathchandra et al. also report that 24 hr LD50 for boiled aqueous extract given 
orally was 7.5 gm /kg body weight for rat.  
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An alternate view found in literature is that the toxicity of C.collinus leaves is not 
attributable to Cleistanthins A and B, as these are not present in the aqueous 
extract of the leaves, and pure forms of the compounds do not cause death in rats 
upto doses as high as 800 mg/kg body weight (Parasuraman and Raveendran, 
2012). LD50 for Cleistanthin A and B are 1200 and 1000 mg/kg respectively 
(Parasuraman and Raveendran, 2012) as per this report.  
In comparison, we report that mld100 for both A and C is 3 mg/100 g BW or 30 
mg/kg. It remains to be seen why Raveendran et al found even 800 mg/kg of 
Cleistanthin A non-toxic.  
Animal experiments play a major role in the toxicological evaluation of drugs/ 
chemical substances. Acute toxicity studies constitute an essential part of such 
investigations. Rodents are mostly used as model system. Controversies still exist 
in the existing methodology for the determination of LD 100. The species and 
number of animals to be used vary with different groups of scientists. Use of large 
number of animals is not advocated since the results are not always reproducible 
even when experiments are repeated under controlled conditions. Hence the use of 
minimum number of animals  and determination of probable range for LD100 
rather than an accurate value are recommended. This point was taken into 
consideration in the present study.  
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Methods section provides information on the protocol for the toxicity experiments 
with the extract of C.collinus. Since chronic toxicity is not reported, all toxicity 
studies were carried  out after administration of single dose of the extract / 
compound. 
 Minimum lethal dose (LD min) is the least amount of drug that can produce 
death in a given animal species under controlled conditions. 
While determining the minimal lethal dose, it was seen that a dose of 30 mg/kg 
body weight of cleistanthin C, when administered by means of oral gavage caused 
100% mortality in all test rats ( n = 4 ). On the other hand, a dose of 750 mg/kg 
body weight of fresh leaf boiled extract gave similar results and caused death in all 
test animals ( n = 4 ). Similar experiments conducted for minimal lethal dose 
estimation for Fresh leaf ground extract  and cleistanthin A yielded the following 
results. For fresh leaf ground extract , 500 mg/ kg body weight achieved 100% 
mortality ( n = 4 ), whereas a dose of  30 mg/ kg body weight was required for 
Cleistanthin A ( n = 4 ).  
As discussed earlier, non fluorescent fraction was believed to contain an antidote 
that could potentially attenuate toxicity mediated by Cleistanthin C. But before 
any experiments could be performed to confirm its antidotal property, non 
fluorescent fraction needed to be analyzed to prove that it was non toxic in 
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isolation. Non fluorescent fraction when given orally at a dose of  200mg/100gm ( 
n=3 ) was seen to be nontoxic. ( For conducting experiments using NFF as the 
antidote and fresh leaf boiled extract as the toxin, a dose of 100 mg / 100 gm body 
weight was used. For experiments where cleistanthin C was the toxin in question, 
NFF at the doses of 8mg/ 100 gm and 100 mg / 100gm body weight was used).  
When experiments were conducted using fresh leaf boiled extract of C. collinus as 
the toxic agent, it was observed that the mortality rate remained unchanged even 
after administration of 100mg/100gm NFF. One observation from this group is 
worth mentioning: of the 3 animals used for the experiment, delayed death was 
observed in one. Reasons for 100% mortality can only be speculated. One cause 
may be the additional presence of Cleistanthin A in fresh leaf boiled extract that 
confers additional toxicity to the isolate over and above the ill effects of 
Cleistanthin C. 
Mortality rate did not show any improvement when NFF was used as an antidote  
at a dose of 8 mg/ 100gm body weight to rats poisoned with cleistanthin C. But 
when the dose of NFF was increased to 100 mg/ 100 gm body weight , a reduction 
in mortality was seen as one out of three rats survived.  
Prolongation of time of death in fresh leaf boiled group  and survival of one rat  in 
Cleistanthin C administered group after administering NFF, may be due to  
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neutralization of  the toxins in the gastrointestinal tract by the “unknown 
compound- putative anti C enzyme” present in the NFF or by an inherent 
detoxification mechanism present in the experimental animal.  
A bigger sample size and a more elaborate study in this area will open new 
avenues in toxicology. This will aid in unravalling mechanisms by which plant 
poisons act and the discovery of their potential antidotes. 
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CONCLUSION 
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CONCLUSIONS 
 
Lethal dose estimation of different clinically relevant extracts of C.collinus were 
done by using minimum number of animals in an iterative manner. Minimal lethal 
dose which caused 100 % mortality for fresh leaf boiled and fresh leaf ground 
extract of C.collinus was found to be 75mg and 50 mg per 100 gram body weight 
of the rat respectively. The major observations are that the fresh leaf juice is as 
poisonous as the boiled decoction in rats. Even if species differences can be 
attributed to difference in humans and rats it still remains to be investigated as to 
why fresh leaf ground extract is toxic in rats. MLD 100 of both Cleistanthin A and 
C was as low as 3mg / 100 gram body weight. The amount of cleistanthin C 
present in minimum lethal dose of fresh leaf boiled extract is considerable. It is 
infact double that of minimal lethal dose of cleistanthin C. Therefore all toxicity of 
fresh leaf boiled extract in rat can be attributed to cleistanthin C. However the 
amount of cleistanthin C in  minimal lethal dose of fresh leaf ground extract is 
lower than non lethal dose of cleistanthin C.therefore cleistanthin C cannot be the 
toxin in FLG. Even the amount of cleistanthin A in minimal lethal dose of  of FLG 
is extremely low and cannot account for the high toxicity of FLG in rats. 
Therefore we conclude that, the toxicity of fresh leaf ground is neither due to 
cleistanthin A or C , but due to a yet unidentified compound. 
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Non fluorescent fraction studies as an antidote was not able to standardize due to 
multiple reasons. Any how ,we were able to do a set of animal experiments as per 
our protocol and we show NFF of 200mg/ 100gm bodyweight when given orally 
is nontoxic. As an antidote, its role has to explored. 
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LIMITATIONS 
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LIMITATIONS 
1.The number of study rats have to be increased. 
2. Dose of NFF, timing of administration, route of administration has to be 
standardized. 
3. Non lethal dose of Cleistanthin A has to be determined. 
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FUTURE 
 PROSPECTS 
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FUTURE PROSPECTIVES 
 
1. Determination of mechanism of toxicity of Cleistanthin C . 
2. Isolation and characterization of two other unknown compounds causing 
prominent  fluorescent bands on thin layer chromatogram of fresh leaf 
ground extract. 
3. Study of toxicity profile of newly identified compounds. 
4. Development of antidote and treatment strategies for Cleistanthus.collinus 
poisoning. 
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